comparemela.com

Latest Breaking News On - First quarter ended june - Page 3 : comparemela.com

Hitachi Construction Machinery : Financial Results for the First Quarter Ended June 30, 2023(IFRS)

Consolidated Financial Results for the First Quarter Ended June 30, 2023 .

Masafumi senzakiBradken ptyHe parts internationalHitachi construction machinery co ltdSpecialized parts service businessConsolidated financial resultsFirst quarter ended junePrime marketExecutive officerQuarterly securities reportFinancial conditionsFiscal year ending marchManagement resultsFinancial conditionFinancial statementsComprehensive income

Nitto Denko : Supplementary Data

Supplementary Data of Consolidated Financial Statements for the First Quarter Ended June 30, 2023 July 26, 2023 NITTO.

Supplementary dataConsolidated financial statementsFirst quarter ended juneBusiness resultsOperating income

Investegate |MUFG Bank, Ltd Announcements | MUFG Bank, Ltd : MUFG Bank, Ltd announces Risk-Adjusted Capital Ratio Based on the Basel 3 Standards for the First Quarter Ended June 30, 2022

Investegate announcements from MUFG Bank, Ltd., MUFG Bank, Ltd. announces Risk-Adjusted Capital Ratio Based on the Basel 3 Standards for the First Quarter Ended June 30, 2022

New yorkUnited statesTakeshi itouTokyo head officeFinancial group incMufg bank ltdBanking corporationBank ltdBanking corporation nonNotification of the financial services agency noPublic relations divisionMitsubishi ufjRisk adjusted capital ratio basedFirst quarter ended juneCommon equity tierRequired capital

Corbus Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Promising pre-clinical data generated for CRB-601 across several tumor models as monotherapy and in combination with anti-PD1 therapy IND submissi.

United statesSean moranMeggan mackayYuval cohenEuropean association for the study of diabetesNational institute of allergyNational institutes of healthAutoimmune centers of excellenceCorbus pharmaceuticalsCorbus pharmaceuticals holdings incExchange commissionSecurities exchangePrnewswire corbus pharmaceuticals holdings incProgram updatesFeinstein institutes for medical researchPharmaceuticals holdings

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

/PRNewswire/ Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life.

Tony russoSusan noonanJim frakesCompany updatesHuman servicesUs department of healthCompany contactDrug administrationSa noonan communicationsPpd incRusso partnersExchange commissionCompany annual report on formSecurities exchangeAethlon medical incBattelle memorial institute

vimarsana © 2020. All Rights Reserved.